Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.42 USD | +1.62% | +3.63% | -16.04% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.04% | 253M | |
+3.15% | 108B | |
+10.37% | 105B | |
+1.57% | 23.46B | |
-12.91% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-7.22% | 17.19B | |
+6.12% | 13.99B | |
+37.00% | 12.53B |
- Stock Market
- Equities
- FENC Stock
- News Fennec Pharmaceuticals Inc.
- Fennec Pharmaceuticals Brief: Full-year 2023 net revenues are expected to be approximately US$20.7 to $21.2 million